Industry News

• Vyvanse® capsules now approved in the US for maintenance treatment in adults with ADHD  Shire announced the FDA approved the prescription medication Vyvanse® (lisdexamfetamine dimesylate) Capsules, as a maintenance treatment for adults with ADHD. The approval is based on results from a randomized withdrawal study designed to evaluate the efficacy of Vyvanse.
  February 07, 2012  
• Administration announces new steps to fight Alzheimer’s disease  The Obama Administration announced new efforts to fight Alzheimer’s disease, including immediately making an additional $50 million available for cutting-edge research. In addition, the administration announced that its FY 2013 budget will boost funding for Alzheimer’s research by $80 million.
  February 07, 2012  
• Sanofi announces FDA approval of Sklice® lotion for treatment of head lice  Sanofi announced that the FDA has approved Sklice® (ivermectin) lotion, 0.5% for the topical treatment of head lice, in patients 6 months of age and older. Effective and well-tolerated, Sklice Lotion treats lice in most patients with a single 10-minute application of the lotion.
  February 07, 2012  
• Mayo Clinic study finds obesity affects severity of symptoms in fibromyalgia patients  People with fibromyalgia can have difficulty getting a definitive diagnosis and finding an effective treatment plan. One factor associated with fibromyalgia symptoms is a patient's weight, according to a Mayo Clinic study published in "Arthritis Care & Research."
  February 07, 2012  
• Prometheus signs research & collaboration agreement with leading pharmaceutical company  Prometheus announced the execution of a research and collaboration agreement with an unnamed leading worldwide pharmaceutical company. The collaboration will use Prometheus’ proprietary oncology diagnostic platform (CEER) to develop diagnostic arrays relating to the partner’s oncology pipeline.
  February 07, 2012  
• Lilly rcognized as a top company for executive women  Eli Lilly has earned a place on the NAFE "Top Companies for Executive Women" list for the fourth consecutive year. The 2012 list, compiled by the National Association for Female Executives, recognizes U.S. companies whose policies and practices encourage women's advancement.
  February 07, 2012  
• Dow AgroSciences, BioDuro to collaborate on crop protection discovery research  Dow AgroSciences and BioDuro, a PPD® Company, announced a three-year, multi-program discovery research agreement to generate novel molecules for synthesizing and testing fungicides, insecticides, and herbicides across a variety of crops.
  February 07, 2012  
• Positive data on AEOL 11207 published in the Journal of Neurobiology of Disease  Aeolus announced the publication of data on AEOL 11207 in epilepsy in Neurobiology of Disease. The study investigated the role of mitochondrial oxidative stress in epilepsy resulting from mitochondrial dysfunction using cross-bred mutant mice lacking mitochondrial manganese superoxide dismutase.
  February 07, 2012  
• Bionovo announces findings of Bezielle™ anticancer properties and active principles  Bionovo announced the publication of two studies that characterize the anticancer properties of its drug Bezielle, and that identify the active principles of the drug. The two papers are published in the Journal of the Public Library of Science One.
  February 07, 2012  
• STERIS announces fiscal 2012 third quarter results  STERIS reported, fiscal 2012 third quarter revenue grew 8% to $355.2 million versus $328.3 million in the 2011 third quarter. Net income for the 2012 third quarter was $33.6 million, or $0.58 per diluted share, versus $21.8 million, or $0.36 per diluted share in the third quarter of fiscal 2011.
  February 07, 2012  

   (next 10 articles)